This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovasculardisease risk in people with type 2 diabetes.
Legume consumption has been linked to a reduced risk of type 2 diabetes (T2D) and cardiovasculardisease (CVD), while the potential association between plasma metabolites associated with legume consumption and.
Olive oil consumption has been inversely associated with the risk of type 2 diabetes (T2D) and cardiovasculardisease (CVD). However, the impact of olive oil consumption on plasma metabolites remains poorly un.
Babies born to pregnant women with obesity are more likely to develop heart problems and diabetes as adults due to fetal damage caused by the high-fat, high-energy diet of their mother.
A new study has found that regular mobile phone use was positively associated with incident cardiovasculardisease risk, especially in current smokers and individuals with diabetes. In addition, this association was partly attributed to poor sleep, psychological distress, and neuroticism.
Diabetes affects millions of Americans. If managed well through proper diet and medication, those with diabetes can lead full and active lives. There are however some serious complications commonly associated with diabetes, like cardiovasculardisease, kidney disease, and PAD (Peripheral Artery Disease).
Diabetic kidney disease (DKD) is associated with a higher risk of cardiovasculardisease (CVD). Pentoxifylline (PTF), a nonselective phosphodiesterase inhibitor with anti-inflammatory, antiproliferative, and a.
More than half of newly diagnosed cases of type 1 diabetes occur in adulthood. This review focuses on the prevention of cardiovasculardisease in patients with type 1 diabetes.
New research has uncovered a surprising culprit underlying cardiovasculardiseases in obesity and diabetes -- not the presence of certain fats, but their suppression. The study challenges the conventional belief that a type of fat called ceramides accumulates in blood vessels causing inflammation and health risks.
BackgroundCurrent evidence suggests that cardiovasculardisease (CVD) plays a role in the progression of chronic obstructive pulmonary disease (COPD). However, the relationship between CVD and the severity of COPD remains inadequately understood.
Cardiovasculardisease (CVD) remains the leading cause of morbidity and mortality in patients with Type 1 Diabetes (T1D). Early markers of CVD include increased carotid intima-media thickness (CIMT) and pulse.
Andrew is a research scientist at Sansum Diabetes Research Institute, where he’s investigating metabolic therapies for health and disease. His mission is to optimize metabolic health and patient outcomes for people living with type 1 diabetes. Andrew is unique because he himself has type 1 diabetes.
A new study found balance and falling were linked to an increased risk of all-cause mortality, as well as cause-specific mortality from cardiovasculardisease and diabetes.
The beneficial effects of fenofibrate on atherosclerotic cardiovasculardisease (ASCVD) outcomes in patients with diabetes and statin treatment are unclear. We investigated the effects of fenofibrate on all-ca.
Evidence from the Look AHEAD study suggests achieving remission in type 2 diabetes is associated with risk reductions in chronic kidney disease and cardiovasculardisease.
years for women with type 2 diabetes. In modeling, the risk for any cardiovasculardisease event among women with a history of hypertensive disorders of pregnancy was generally 10% to 20% higher, with main models estimating hazard ratios to 1.20 (95% CI, 0.99–1.47) years for women with type 1 and 29.8
This new insight into the flow of fats through the body points to new therapeutic targets for mitigating diseases like ASCVD, non-alcoholic fatty liver disease, obesity, diabetes, peripheral neuropathy, and neurodegeneration.
million new cases of type 2 diabetes and 1.2 million new cases of cardiovasculardisease occur each year globally due to consumption of sugar-sweetened beverages. Friedman School of Nutrition Science and Policy at Tufts University, published in Nature Medicine, estimates that 2.2
Objective Population-based national data on the trends in expenditures related to coexisting atherosclerotic cardiovasculardiseases (ASCVD) and diabetes is scarce. Individuals with diabetes had a 1.5-fold fold higher mean expenditure that those without diabetes. individuals aged ≥ 18 years.
Objective We aimed to summarize the association between gestational diabetes mellitus (GDM) and its intergenerational cardiovasculardiseases (CVDs) impacts in both mothers and offspring post-delivery in existing literature.
Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM), which researchers note may have the potential to inform clinical practice, interventions, and policies.
BackgroundType 2 diabetes (T2D) is a major risk factor for atherosclerotic cardiovasculardisease (ASCVD). Journal of the American Heart Association, Ahead of Print. A weighted polygenic risk score for T2D was calculated on the basis of 138 genetic variants associated with T2D.
Background Current clinical guidelines on cardiovasculardisease (CVD) do not specifically address the female population. The aim of this consensus is to know the opinion of a group of experts on the management of CVD in women.
Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovasculardisease. During the 4.22-year
Foot ulcers and/or infections are common long-term complications of diabetes and are associated with increased mortality, especially from cardiovasculardisease, though only a few studies have investigated the.
(MedPage Today) -- NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic cardiovasculardisease (ASCVD) were under-prescribed guideline-recommended treatment with sodium-glucose cotransporter.
Hypertension, cardiovasculardisease and kidney failure are associated with persistent hyperglycaemia and the subsequent development of nephropathy in people with diabetes. Diabetic nephropathy is associated w.
Among participants with type 2 diabetes and cardiovasculardisease, chronic kidney disease, or both, oral semaglutide (14 mg) was associated with a lower risk of cardiovascular events than placebo after 4 years of follow-up.
The triglyceride-glucose (TyG) index is recognized as an indicator of insulin resistance and is linked to cardiovasculardisease (CVD) in patients with type 2 diabetes. However, its utility in patients with Ty.
A systematic review of over 400 studies in type 2 diabetes reveals 13 biomarkers, including NT-proBNP and troponin-t, with potential to significantly enhance cardiovasculardisease risk prediction.
Cardiovasculardisease represents a significant risk factor for mortality in individuals with type 2 diabetes mellitus (T2DM). High-density lipoprotein (HDL) is believed to play a crucial role in maintaining c.
Eating patterns that align with the Mediterranean diet or the dietary approaches to stop hypertension (DASH) diet could help lower cardiovasculardisease risk in adults with type 1 diabetes, according to results from a six-year study.
With Medicare now covering semaglutide for people with obesity and cardiovasculardisease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans apply.
. -- A pharmacist-led intervention using notes in the electronic health record (EHR) proved effective for convincing primary care providers to switch veterans with diabetes and cardiovasculardisease (CVD) to.
Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovasculardisease, cognitive impairment, and frailty also share the following risk factors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.
Preeclampsia (PE) and type 1 diabetes (T1D) are significant risk factors for cardiovasculardisease (CVD), but their combined effect on atherosclerosis progression has not been fully explored. This study aimed.
IntroductionThe present study aimed to examine the additive interaction of family medical history of cardiovasculardisease (CVD) and self-reported hypertension and diabetes on the diagnosis of CVD among older adults aged 45 years and above in India. In the adjusted model, RERI, AP, and S for CVD were 2.30 (95% CI: 0.87–3.74),
What role do omega-6 fatty acids play in cardiovasculardisease and diabetes? Scientists from Mannheim, together with researchers from Heidelberg, Frankfurt, and Hangzhou in China, have investigated the breakdown of omega-6 fatty acids and gained new insights into how their oxidation products influence the metabolism.
New research at the Roy Blunt NextGen Precision Health building has discovered a potential treatment for an underlying cause of cardiovasculardisease in people with type 2 diabetes.
Clonal hematopoiesis of indeterminate potential (CHIP) was associated with diabetes and cardiovasculardiseases (CVD). However, the effect of CHIP on CVD have not been evaluated among patients with diabetes, a.
The five classic risk factors for cardiovasculardisease are well knownsmoking, high blood pressure, high cholesterol, diabetes, and underweight or overweight/obesity. All increase the likelihood of heart ailments down the road.
Insulin resistance proxy indicators are significantly associated with cardiovasculardisease (CVD) and diabetes. However, the correlations between the estimated glucose disposal rate (eGDR) index and CVD and i.
For people with HIV (PWH) with low-to-moderate atherosclerotic cardiovasculardisease (ASCVD) risk, metabolic risk factors contribute to new-onset diabetes mellitus (DM) among those treated with pitavastatin or placebo, according to a study published online Oct. 8 in the Annals of Internal Medicine.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content